These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21071997)

  • 21. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations in vitro.
    Zollinger M; Waldmeier F; Hartmann S; Zenke G; Zimmerlin AG; Glaenzel U; Baldeck JP; Schweitzer A; Berthier S; Moenius T; Grassberger MA
    Drug Metab Dispos; 2006 May; 34(5):765-74. PubMed ID: 16467136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
    Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
    Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and enantioselective pharmacokinetics of Casodex in man.
    McKillop D; Boyle GW; Cockshott ID; Jones DC; Phillips PJ; Yates RA
    Xenobiotica; 1993 Nov; 23(11):1241-53. PubMed ID: 8310708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The disposition and metabolism of [14C]fluconazole in humans.
    Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
    Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
    Polsky-Fisher SL; Vickers S; Cui D; Subramanian R; Arison BH; Agrawal NG; Goel TV; Vessey LK; Murphy MG; Lasseter KC; Simpson RC; Vega JM; Rodrigues AD
    Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of 1-naphthol in the channel catfish (Ictalurus punctatus).
    Stehly GR; Plakas SM
    Drug Metab Dispos; 1992; 20(1):70-3. PubMed ID: 1347000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers.
    Stopfer P; Rathgen K; Bischoff D; Lüdtke S; Marzin K; Kaiser R; Wagner K; Ebner T
    Xenobiotica; 2011 Apr; 41(4):297-311. PubMed ID: 21204634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).
    Di Stefano AF; Radicioni MM; Rusca A
    Neurotox Res; 2013 May; 23(4):315-26. PubMed ID: 22872464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, metabolism and excretion of [(14)C]-lanicemine (AZD6765), a novel low-trapping N-methyl-d-aspartic acid receptor channel blocker, in healthy subjects.
    Guo J; Zhou D; Grimm SW; Bui KH
    Xenobiotica; 2015 Mar; 45(3):244-55. PubMed ID: 25259653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers.
    Chen LZ; Jungnik A; Mao Y; Philip E; Sharp D; Unseld A; Seman L; Woerle HJ; Macha S
    Xenobiotica; 2015; 45(6):520-9. PubMed ID: 25547626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism, excretion and pharmacokinetics of [
    Lam JL; Vaz A; Hee B; Liang Y; Yang X; Shaik MN
    Xenobiotica; 2017 Dec; 47(12):1064-1076. PubMed ID: 27866461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption, metabolism and excretion of darexaban (YM150), a new direct factor Xa inhibitor in humans.
    Hashimoto T; Suzuki K; Kihara Y; Iwatsubo T; Miyashita A; Heeringa M; Onkels H; Groenendaal D; Verheggen F; van Marle S; Usui T
    Xenobiotica; 2013 Jun; 43(6):534-47. PubMed ID: 23167531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.